Tech Company Financing Transactions

Complement Therapeutics Funding Round

Complement Therapeutics closed a $78.9 million funding round on 4/17/2023. Investors included Forbion Capital Partners, GIMV and BioGeneration Ventures.

Transaction Overview

Company Name
Complement Therapeutics
Announced On
4/17/2023
Transaction Type
Venture Equity
Amount
$78,933,000
Round
Undisclosed
Investors

Forbion Capital Partners (Lead Investor)

GIMV (Lead Investor) (Michaël Vlemmix)

BioGeneration Ventures

Cambridge Innovation Capital (Anne Horgan)

Hadean Ventures (Roger Franklin)

Panakes Partners (Rob Woodman)

Seroba Life Sciences

Proceeds Purpose
The company intends to use the funds to continue the development and complete a Phase Ib clinical proof of concept of its lead product CTx001, to grow its laboratory-based activities in Stevenage (UK), evaluate its pipeline assets for non-ocular indications as well as further develop the novel Complement Precision Medicine (CPM) platform.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
84 Wood Lane
London England, W12 0BZ
UK
Phone
Undisclosed
Website
www.complementtx.com
Email Address
[email protected]
Overview
Complement Therapeutics (CTx) is an early-stage biotechnology company focused on the research and development of novel therapeutics for complement-mediated diseases. The Company is a spinout from the University of Manchester and is based on the pioneering research of its founders into novel targets within the complement cascade.
Profile
Complement Therapeutics LinkedIn Company Profile
Social Media
Complement Therapeutics Company Twitter Account
Company News
Complement Therapeutics News
Facebook
Complement Therapeutics on Facebook
YouTube
Complement Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Rafiq Hasan
  Rafiq Hasan LinkedIn Profile  Rafiq Hasan Twitter Account  Rafiq Hasan News  Rafiq Hasan on Facebook
Chief Scientific Officer
Dennis Keefe
  Dennis Keefe LinkedIn Profile  Dennis Keefe Twitter Account  Dennis Keefe News  Dennis Keefe on Facebook
Founder
Paul Bishop
  Paul Bishop LinkedIn Profile  Paul Bishop Twitter Account  Paul Bishop News  Paul Bishop on Facebook
Founder
Simon Clark
  Simon Clark LinkedIn Profile  Simon Clark Twitter Account  Simon Clark News  Simon Clark on Facebook
Founder
Richard Unwin
  Richard Unwin LinkedIn Profile  Richard Unwin Twitter Account  Richard Unwin News  Richard Unwin on Facebook

 

 

Browse more venture capital transactions:

Prev: 4/17/2023: Uxuy venture capital transaction
Next: 4/17/2023: Yonder venture capital transaction

 

Share this article

 

About Our Venture Capital Transactions Database

We do our best to document every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.